Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : URMD -- Huge market potential -- Ignore unavailable to you. Want to Upgrade?

To: Hugh A. McWhorter who wrote (191)	1/13/1998 1:18:00 PM
From: Samuel J. Bennett	Read Replies (1) \| Respond to of 369

Hugh; My investment in Uromed is much more substantial, based on the very facts that you mentioned;no sales. This is still a development company and a start up operation. I invest in these type companies if I expect a very large return when operations begin. They will begin this quarter. The projected sales for the Impress patch is 50 million units for 1998. The projected market for the Breast Self Exam device is in the $1 billion, and so on for the Cavermap. Worth my hanging on for a while. sam